retatrutide type 2 diabetes trial nct Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Phase 2 Trial of Retatrutide

Powell, C

Lee SA, Kim YR, Yang EJ, Kwon EJ, Kim SH, Kang SH, et al

Sauna: Increases circulation Stimulates sweat Activates heat shock proteins Encourages metabolic turnover TUDCA: Supports bile flow Protects liver cells Reduces ER stress Enhances detox capacity Together, they may create a more coordinated response mobilizing compounds while supporting the pathways that eliminate them.* Reducing Cellular Stress While Increasing Detox Load Heat exposure temporarily increases oxidative stress

Most clients notice increased energy and a feeling of rejuvenation shortly after the first session

Symptoms can be mild to severe and fluctuate dramatically

For instance, anthocyanins and NAC maintain the activity of the sodiumpotassium pump through their own antioxidant capabilities, demonstrating the effects of enhanced physical strength and endurance, respectively (105)